Zoltrot 2.5 Tablet contains Zolmitriptan 2.5mg, a selective serotonin receptor agonist used for the acute treatment of migraine attacks, with or without aura. It helps relieve headache pain and associated symptoms such as nausea, sensitivity to light, and sound.
Zolmitriptan works by stimulating serotonin (5-HT1B/1D) receptors in the brain, leading to constriction of dilated cranial blood vessels and inhibition of pain signal transmission involved in migraine attacks.
This tablet is commonly prescribed for patients experiencing moderate to severe migraine episodes, providing rapid relief when taken at the onset of symptoms, under medical guidance.
Zoltrot 2.5 Tablet is valued for its fast onset of action, reliable symptom control, and consistent clinical effectiveness. Its role in acute migraine management makes it an important option in neurology-focused treatment protocols and headache care programs.
Common side effects may include dizziness, drowsiness, nausea, dry mouth, tingling sensation, and fatigue. Less common side effects include chest discomfort, palpitations, or blood pressure changes. Serious adverse effects are rare when used as prescribed.
Zoltrot 2.5 Tablet is indicated for the acute treatment of migraine with or without aura in adults. It helps reduce headache intensity along with associated symptoms such as nausea, vomiting, photophobia, and phonophobia.
Zoltrot 2.5 Tablet should be taken only under medical advice. It is not intended for migraine prevention or for treating other types of headaches. Use with caution in patients with cardiovascular risk factors, hypertension, or hepatic impairment. Do not exceed the recommended dose.
Store Zoltrot 2.5 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and use before the expiry date printed on the pack.